Identification of Independent and Communal Differentially Expressed Genes as Well as Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure

被引:1
|
作者
Wang, Zuoxiang [1 ,2 ]
Zhang, Mingyang [1 ,2 ]
Xu, Yinan [1 ,2 ]
Gu, Yiyu [1 ,2 ]
Song, Yumeng [1 ,2 ]
Jiang, Tingbo [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, 188 Shizi Rd, Suzhou 215006, Jiangsu, Peoples R China
[2] Soochow Univ, Dept Med, Suzhou, Jiangsu, Peoples R China
来源
PHARMACOGENOMICS & PERSONALIZED MEDICINE | 2021年 / 14卷
关键词
bioinformatical analysis; differentially expressed genes; hub genes; heart failure; ischemic heart failure; non-ischemic heart failure; INTEGRATION; NETWORKS; ETIOLOGY; SERVER;
D O I
10.2147/PGPM.S313621
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Heart failure (HF) is a rapidly growing public health problem, and its two main etiological types are non-ischemic heart failure (NIHF) and ischemic heart failure (IHF). However, the independent and common mechanisms of NIHF and IHF have not been fully elucidated. Here, bioinformatic analysis was used to characterize the difference and independent pathways for IHF and NIHF, and more importantly, to unearth the common potential markers and therapeutic targets in IHF and NIHF. Methods: Two data sets with accession numbers GSE26887 and GSE84796 were downloaded from the Gene Expression Omnibus (GEO) database. After identifying the independent and communal DEGs of NIHF and IHF, a functional annotation, protein-protein interaction (PPI) network analysis, co-expression and drug-gene interaction prediction analysis, and mRNA-miRNA regulatory network analysis were performed for DEGs. Results: We found 1146 independent DEGs (DEGs2) of NIHF mainly enriched in transcription-related and 2595 independent DEGs (DEGs3) of IHF mainly enriched in immune-related. Moreover, 185 communal DEGs (DEGs1) were found between NIHF and IHF, including 93 upregulated genes and 92 downregulated genes. Pathway enrichment analysis results showed that GPCR pathways and biological processes are closely related to the occurrence of HF. In addition, three hub genes were identified from PPI network, including CCL5, C5 and TLR3. Conclusion: The identification of DEGs and hub genes in this study contributes to a novel perception for potential functional mechanisms and biomarkers or therapeutic targets in NIHF and IHF.
引用
收藏
页码:683 / 693
页数:11
相关论文
共 50 条
  • [31] Moderate continuous or high intensity interval exercise in heart failure with reduced ejection fraction: Differences between ischemic and non-ischemic etiology
    Halle, Martin
    Prescott, Eva
    Craenenbroeck, Emeline M. Van
    Beckers, Paul
    Videm, Vibeke
    Karlsen, Trine
    Feiereisen, Patrick
    Winzer, Ephraim B.
    Mangner, Norman
    Snoer, Martin
    Christle, Jeffrey W.
    Dalen, Havard
    Stoylen, Asbjorn
    Esefeld, Katrin
    Heitkamp, Melanie
    Spanier, Bianca
    Linke, Axel
    Ellingsen, Oyvind
    Delagardelle, Charles
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 22
  • [32] Usefulness of Phase Analysis to Differentiate Ischemic and Non-Ischemic Etiologies of Left Ventricular Systolic Dysfunction in Patients With Heart Failure
    Igarashi, Yuko
    Chikamori, Taishiro
    Hida, Satoshi
    Tanaka, Hirokazu
    Shiba, Chie
    Usui, Yasuhiro
    Hatano, Tuguhisa
    Yamashina, Akira
    CIRCULATION JOURNAL, 2014, 78 (01) : 141 - 150
  • [33] Effectiveness of Implantable Cardioverter-Defibrillator Therapy for Heart Failure Patients according to Ischemic or Non-Ischemic Etiology in Korea
    Park, Kyu-Hwan
    Lee, Chan-Hee
    Jung, Byung Chun
    Cho, Yongkeun
    Bae, Myung Hwan
    Kim, Yoon-Nyun
    Park, Hyoung-Seob
    Han, Seongwook
    Lee, Young Soo
    Hyun, Dae-Woo
    Kim, Jun
    Kim, Dae Kyeong
    Cha, Tae-Jun
    Shin, Dong-Gu
    KOREAN CIRCULATION JOURNAL, 2017, 47 (01) : 72 - 81
  • [34] Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats
    Cheng, Gang
    Xu, Geng
    Cai, Hong-Wen
    Wang, Hui-Hua
    Bao, Xiao-Feng
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (04) : 511 - 517
  • [35] Cardiopulmonary exercise responses in patients with non-ischemic heart failure and a mildly reduced ejection fraction
    Harada, Ken
    Yamada, Sumio
    Mamiya, Kumiko
    Higo, Sayaka
    Suzuki, Hitomi
    Teshima, Yuto
    Matsunaga, Shun
    Harada, Kazuhiro
    Nagao, Tomoyuki
    Shinoda, Norihiro
    Kato, Masataka
    Marui, Nobuyuki
    Amano, Tetsuya
    Murohara, Toyoaki
    FUTURE CARDIOLOGY, 2022, 18 (08) : 627 - 634
  • [36] Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats
    Gang Cheng
    Geng Xu
    Hong-wen Cai
    Hui-hua Wang
    Xiao-feng Bao
    Acta Pharmacologica Sinica, 2007, 28 : 511 - 517
  • [37] Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure
    Karabacak, Mustafa
    Dogan, Abdullah
    Tayyar, Senol
    Ozaydin, Mehmet
    Erdogan, Dogan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (04): : 271 - 276
  • [38] Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure
    S. Göbel
    A. S. Braun
    O. Hahad
    U. von Henning
    M. Brandt
    K. Keller
    M. M. Gaida
    T. Gori
    H. P. Schultheiss
    F. Escher
    T. Münzel
    P. Wenzel
    Clinical Research in Cardiology, 2024, 113 : 737 - 749
  • [39] A Comparison of the Effects of Carvedilol and Nebivolol on Oxidative Stress Markers in Patients with Non-ischemic Heart Failure
    Karabacak, Mustafa
    Dogan, Abdullah
    Kahraman, Fatih
    Turkdogan, Ahmet Kenan
    Tayyar, Senol
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C108 - C108
  • [40] Is the Myocardium Oxygen Deprived in Non Ischemic Heart Failure?
    Dass, Sairia
    Holloway, Cameron J.
    Suttie, Joseph
    Mahmod, Masliza
    Dwight, Jeremy F.
    Watkins, Hugh
    Neubauer, Stefan
    Karamitsos, Theodoros D.
    CIRCULATION, 2013, 128 (22)